Schedule 13D ownership disclosure

DICERNA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 253031108

Event date: 2018-01-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,462,313
Percent of class
8.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-002889
Form type
SC 13D/A
Filer
Dicerna Pharmaceuticals Inc
CIK
CIK 1399529
Filed
Jan 19, 2018
Reporting period
Jan 17, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub